AGP Executive Report
Last update: 8 hours agoCancer Care Update: The Emirates Drug Establishment has approved AstraZeneca’s oral targeted therapy Etcamah for UAE patients with advanced/metastatic breast cancer that becomes resistant to hormone therapy due to an ESR1 gene mutation. Public Health & Innovation: Dubai launched the UAE’s first publicly neurodivergent-owned mental health center, UniQuely You, offering therapy for ages 13 to 60+ with a neurodiversity-affirming approach. Longevity Push: Dubai issued a law creating the Dubai Longevity Authority to position the emirate as a regulated hub for longevity, wellness and advanced healthcare innovation. Road Safety & Support: Dubai Police visited survivors of a deadly Emirates Road minibus-truck crash at Rashid Hospital, checking on their condition and offering support. Healthcare Tech & Access: UAE-linked AI is being used for faster prostate cancer detection, with NRL deploying AI-powered diagnostics. Market Watch: Wegovy weight-loss treatment is reported as available in UAE pharmacies, with pricing and guidance drawing attention.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/af9c6fb4-2b61-4367-852e-7237ba1d9bc4/north-america-gastrointestinal-endoscopy-devices-market-size-2025-to-2035-usd-billion-.png)
